Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study. (Q53191415)
Jump to navigation
Jump to search
scientific article published on 21 September 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study. |
scientific article published on 21 September 2015 |
Statements
Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study (English)
Sun Hwa Kim
Sin Gon Kim
Doo Man Kim
Jeong-Taek Woo
Hak Chul Jang
Kyung Soo Ko
Jeong Hyun Park
Yong Soo Park
Sang Jin Kim
Dong Seop Choi
21 September 2015